Applied Finance Capital Management’s Gilead Sciences GILD Stock Holding History

Applied Finance Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Sell	14,693 -5,594	-28%	-$737K	0.14%	74
2026 Q1	$2.83M	Sell	20,287 -757	-4%	-$106K	0.21%	65
2025 Q4	$2.58M	Buy	21,044 +6,004	+40%	+$730K	0.19%	67
2025 Q3	$1.67M	Sell	15,040 -1,056	-7%	-$120K	0.12%	71
2025 Q2	$1.78M	Sell	16,096 -6,564	-29%	-$699K	0.12%	75
2025 Q1	$2.54M	Sell	22,660 -479	-2%	-$49.4K	0.19%	62
2024 Q4	$2.14M	Sell	23,139 -1,343	-5%	-$121K	0.09%	62
2024 Q3	$2.05M	Buy	24,482 +1,714	+8%	+$131K	0.09%	63
2024 Q2	$1.56M	Buy	+22,768	New	+$1.52M	0.07%	73

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Applied Finance Capital Management's GILD Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Gilead Sciences (GILD) stake by 28% in Q2 2026, selling an estimated $737K and leaving 14,693 shares worth $1.86M. The position accounts for 0.14% of the portfolio, ranked #74.

Applied Finance Capital Management first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.83M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Applied Finance Capital Management held 14,693 shares of Gilead Sciences worth $1.86M as of Q2 2026.
Applied Finance Capital Management sold 5,594 Gilead Sciences shares in Q2 2026, an estimated $737K.
Gilead Sciences made up 0.14% of Applied Finance Capital Management's portfolio in Q2 2026, its #74 holding.
Applied Finance Capital Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Applied Finance Capital Management's Gilead Sciences position peaked at $2.83M in Q1 2026.
2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.